Paul N. Durrington

1976–2026 年に発表

別表記
Paul N Durrington
113
論文数
32,449
被引用数
83
h 指数
112
i10 指数

被引用数

Paul N. Durrington の年別被引用数1964 年: 被引用 2 件1972 年: 被引用 1 件1977 年: 被引用 1 件1978 年: 被引用 2 件1979 年: 被引用 7 件1980 年: 被引用 2 件1982 年: 被引用 1 件1983 年: 被引用 4 件1984 年: 被引用 5 件1985 年: 被引用 3 件1986 年: 被引用 3 件1987 年: 被引用 5 件1988 年: 被引用 7 件1989 年: 被引用 10 件1990 年: 被引用 14 件1991 年: 被引用 17 件1992 年: 被引用 24 件1993 年: 被引用 22 件1994 年: 被引用 29 件1995 年: 被引用 45 件1996 年: 被引用 30 件1997 年: 被引用 71 件1998 年: 被引用 127 件1999 年: 被引用 88 件2000 年: 被引用 128 件2001 年: 被引用 143 件2002 年: 被引用 153 件2003 年: 被引用 235 件2004 年: 被引用 240 件2005 年: 被引用 192 件2006 年: 被引用 251 件2007 年: 被引用 192 件2008 年: 被引用 222 件2009 年: 被引用 241 件2010 年: 被引用 177 件2011 年: 被引用 250 件2012 年: 被引用 263 件2013 年: 被引用 321 件2014 年: 被引用 309 件2015 年: 被引用 335 件2016 年: 被引用 306 件2017 年: 被引用 215 件2018 年: 被引用 159 件2019 年: 被引用 619 件2020 年: 被引用 534 件2021 年: 被引用 452 件2022 年: 被引用 380 件2023 年: 被引用 314 件2024 年: 被引用 412 件2025 年: 被引用 177 件2026 年: 被引用 25 件1965〜1971 年は被引用が無いため表示していません1973〜1976 年は被引用が無いため表示していません1981 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,057 件、この内訳の 19.5%イギリス: 引用元論文 1,129 件、この内訳の 10.7%イタリア: 引用元論文 548 件、この内訳の 5.2%中国: 引用元論文 458 件、この内訳の 4.3%カナダ: 引用元論文 434 件、この内訳の 4.1%オランダ: 引用元論文 405 件、この内訳の 3.8%オーストラリア: 引用元論文 403 件、この内訳の 3.8%フランス: 引用元論文 393 件、この内訳の 3.7%ドイツ: 引用元論文 391 件、この内訳の 3.7%スペイン: 引用元論文 337 件、この内訳の 3.2%スウェーデン: 引用元論文 274 件、この内訳の 2.6%日本: 引用元論文 203 件、この内訳の 1.9%
0%19.5%その他 33.5%

分野

  • Medicine67.8%
  • Biochemistry, Genetics and Molecular Biology22.3%
  • Nursing3.3%
  • Immunology and Microbiology1.5%
  • Agricultural and Biological Sciences1%
  • Health Professions0.7%
  • その他3.4%

トピック

  • Lipoproteins and Cardiovascular Health11.1%
  • Diabetes, Cardiovascular Risks, and Lipoproteins8.9%
  • Paraoxonase enzyme and polymorphisms3.4%
  • Cancer, Lipids, and Metabolism2.9%
  • Atherosclerosis and Cardiovascular Diseases1.7%
  • Diabetes Treatment and Management1.7%
  • その他70.3%

共著者

全論文

検索で開く
  1. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heather Halls, Charlie Harper, C. Hawkins, William G. Herrington, G. A. Hitman, Hallvard Holdaas, Lisa Holland, Alan G. Jardine, J. Wouter Jukema, John J.P. Kastelein, Sharon Kean, Anthony Keech, Adrienne Kirby, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Wolfgang Köenig, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Eva Lonn, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Ian C. Marschner, Borislava Mihaylova, Lemuel A. Moyé, Sabina A. Murphy, Haruo Nakamura, Andrew Neil, Connie B. Newman, Rachel O’Connell, Chris J. Packard, Sarah Parish, Terje Pedersen, Richard Peto, Marc A. Pfeffer, Neil Poulter, David Preiss, Christina Reith, Paul M. Ridker, Michele Robertson, Frank M. Sacks, Naveed Sattar, Roland E. Schmieder, Patrick W. Serruys, Peter Sever, John Shaw, Charles L. Shear, John Simes, Peter Sleight, Enti Spata, Luigi Tavazzi, Jonathan A. Tobert, Gianni Tognoni, Andrew Tonkin, Stella Trompet, George Varigos, Christoph Wanner, Hans Wedel, Harvey D. White, John Wikstrand, Lars Wilhelmsen, Kate Wilson, Robin Young, Salim Yusuf, Faı̈ez Zannad - The Lancet 2019 被引用: 791

  2. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

    著者: , , , , , , , , , - The Lancet 2004 被引用: 3,791

  3. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Clearfield, Stuart M. Cobbe, Helen M. Colhoun, Björn Dahlöf, Barry R. Davis, James A. de Lemos, John R. Downs, Paul N. Durrington, Bengt Fellström, Ian Ford, Maria Grazia Franzosi, John A. Fuller, Curt D. Furberg, Robert J. Glynn, David Gordon, Antonio M. Gotto, Richard H. Grimm, Ajay Gupta, C. Hawkins, G. A. Hitman, Hallvard Holdaas, Alan G. Jardine, J. Wouter Jukema, John J.P. Kastelein, Sharon Kean, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Wolfgang Köenig, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Roberto Latini, Eva Lonn, Donata Lucci, Jean MacFadyen, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Ian C. Marschner, Lemuel A. Moyé, Sabina A. Murphy, Andrew Neil, Enrico Nicolis, Chris J. Packard, Sarah Parish, Terje R. Pedersen, Richard Peto, Marc A. Pfeffer, Neil R Poulter, Sara Pressel, Jeffrey L. Probstfield, Mahboob Rahman, Paul M. Ridker, Michele Robertson, Frank M. Sacks, Naveed Sattar, Roland E. Schmieder, Patrick W. Serruys, Peter Sever, John Shaw, James Shepherd, Lara M. Simpson, Peter Sleight, Luigi Tavazzi, Gianni Tognoni, Andrew Tonkin, Stella Trompet ほか 28 名 - The Lancet 2022 被引用: 246

  4. Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stella Trompet, Harvey D. White, Salim Yusuf, Jane Armitage, Anthony Keech, John Simes, Rory Collins, Colin Baigent, Elizabeth H Barnes, Jordan Fulcher, William G. Herrington, Adrienne Kirby, Rachel O’Connell, Pierre Amarenco, Hiroyuki Arashi, Philip J. Barter, D. J. Betteridge, Michael A. Blazing, Gerard J Blauw, Jackie Bosch, Louise Bowman, Eugene Braunwald, Richard Bulbulia, Robert Byington, Michael Clearfield, Stuart M. Cobbe, Björn Dahlöf, Barry R. Davis, James A. de Lemos, John R. Downs, Bengt Fellström, Marcus Flather, Ian Ford, Maria Grazia Franzosi, John A. Fuller, Curt D. Furberg, Robert J. Glynn, Uri Goldbourt, David Gordon, Antonio M. Gotto, Richard Grimm, A Gupta, C. Hawkins, Richard Haynes, Hallvard Holdaas, Jemma C. Hopewell, Alan G. Jardine, John J.P. Kastelein, Sharon Kean, Patricia M. Kearney, George D. Kitas, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Roberto Latini, Eva Lonn, Donata Lucci, Jean MacFadyen, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Lemuel A. Moyé, Sabina A. Murphy, Andrew Neil, Enrico Nicolis ほか 32 名 - The Lancet Diabetes & Endocrinology 2024 被引用: 137

  5. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R. Hobbs, Arno W. Hoes, Patricia M. Kearney, Juhani Knuuti, Philippe Kolh, T. McDonagh, Bruno Moulin, D Poldermans, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, P. A. Sirnes, Michał Tendera, Adam Torbicki, P. Vardas, P. Widimsky, Stephan Windecker, Document Reviewers, Christian Funck‐Brentano, D Poldermans, G. Berkenboom, Jacqueline de Graaf, Olivier Descamps, Nina Gotcheva, K. Griffith, Giuseppe Guida, S. Gulec, Y Henkin, Kurt Huber, Y. Antero Kesäniemi, J. Lekakis, Athanasios Manolis, Pedro Marques‐Vidal, L. Masana, John J.V. McMurray, Eugénia Mendes, Zurab Pagava, Terje Pedersen, Eva Prescott, Quitéria Rato, Giuseppe Rosano, Susana Sans, A. Stalenhoef, Lâle Tokgözoğlu, Margus Viigimaa, M. E. Wittekoek, José Luis Zamorano - European Heart Journal 2011 被引用: 3,547

  6. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , A. Dudina, Alec Vahanian, A. John Camm, R. De Caterina, V. Dean, Kenneth Dickstein, Christian Funck‐Brentano, G. Filippatos, Irene Hellemans, S. D. Kristensen, Keith McGregor, U Sechtem, Sigmund Silber, Michał Tendera, P. Widimsky, José Luis Zamorano, Document reviewers:, Irene Hellemans, Attila Altiner, Enzo Bonora, Paul N. Durrington, R. Fagard, Simona Giampaoli, Harry Hemingway, Jan Håkansson, Sverre E. Kjeldsen, M. Lytken Larsen, G. Mancia, Athanasios Manolis, Kristina Orth‐Gomér, Terje Pedersen, Mike Rayner, L Rydén, Mario R. Sammut, Neil Schneiderman, Anton F. H. Stalenhoef, Lâle Tokgözoğlu, Olov Wiklund, Antonis Zampelas - European Heart Journal 2007 被引用: 3,758

  7. Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins

    著者: , , , , , , , , , , , , , , , , , , - JAMA 2012 被引用: 798

  8. Antioxidant properties of HDL

    著者: , , - Frontiers in Pharmacology 2015 被引用: 185

  9. Improvements in Diabetic Neuropathy and Nephropathy After Bariatric Surgery: a Prospective Cohort Study

    著者: , , , , , , , , , , , , , , , , , , - Obesity Surgery 2020 被引用: 77

  10. Paraoxonase 1 and atherosclerosis

    著者: , , - Frontiers in Cardiovascular Medicine 2023 被引用: 69

  11. Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome—Causes, Clinical Presentation, and Therapeutic Options

    著者: , , , , , , , , , , , , , , , , - Metabolites 2023 被引用: 40

  12. Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alice Stanton, Denis C. Shields, Eoin OʼBrien, Sue Shaw‐Hawkins, Yu Chen, Deborah A. Nickerson, Joshua D. Smith, Marie‐Pierre Dubé, S. Matthijs Boekholdt, G. Kees Hovingh, John J.P. Kastelein, Paul McKeigue, John Betteridge, Andrew Neil, Paul N. Durrington, Alex S. F. Doney, Fiona Carr, Andrew P. Morris, Mark I. McCarthy, Leif Groop, Emma Ahlqvist, Joshua C. Bis, Kenneth Rice, Nicholas L. Smith, Thomas Lumley, Eric A. Whitsel, Til Stürmer‎, Eric Boerwinkle, Julius S. Ngwa, Christopher J. O’Donnell, Ramachandran S. Vasan, Wei‐Qi Wei, Russell A. Wilke, Ching‐Ti Liu, Fangui Sun, Xiuqing Guo, Susan R. Heckbert, Wendy S. Post, Nona Sotoodehnia, Alice M. Arnold, Jeanette M. Stafford, Jingzhong Ding, David M. Herrington, Stephen B. Kritchevsky, Guðný Eiríksdóttir, Leonore J. Launer, Tamara B. Harris, Audrey Y. Chu, Franco Giulianini, Jean MacFadyen, Bryan J. Barratt, Fredrik Nyberg, Bruno H. Stricker, André G. Uitterlinden, Albert Hofman, Fernando Rivadeneira, Valur Emilsson, Oscar H. Franco, Paul M. Ridker, Vilmundur Guðnason, Ching‐Ti Liu, Joshua C. Denny, Christie M. Ballantyne, Jerome I. Rotter, L. Adrienne Cupples, Bruce M. Psaty, Colin N. A. Palmer, Jean‐Claude Tardif, Helen M. Colhoun, G. A. Hitman ほか 64 名 - Nature Communications 2014 被引用: 279

  13. Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta‐analysis of randomized controlled trials

    著者: , , , , , , , - Journal of Internal Medicine 2008 被引用: 227

  14. Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients

    著者: , , , , , , , , , , , , , , , , , , , , - Circulation 2013 被引用: 194

  15. Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein

    著者: , , - FEBS Letters 1991 被引用: 978

  16. Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2009 被引用: 338

  17. Bariatric surgery leads to an improvement in small nerve fibre damage in subjects with obesity

    著者: , , , , , , , , , , , , , , , , , - International Journal of Obesity 2021 被引用: 51

  18. Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records

    著者: , , , , , , , , , , - Atherosclerosis 2020 被引用: 42

  19. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study

    著者: , , , , , , , , - European Heart Journal 2008 被引用: 424

  20. Glycation as an atherogenic modification of LDL

    著者: , , , , , - Current Opinion in Lipidology 2008 被引用: 95

  21. Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape—focus on hypertriglyceridaemia

    著者: , , , , , , , , , , - Frontiers in Cardiovascular Medicine 2024 被引用: 30

  22. Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)

    著者: , , , , , , , , - American Journal of Kidney Diseases 2009 被引用: 254

  23. Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register

    著者: , , , , , , , , - Atherosclerosis 2018 被引用: 96

  24. Targets of Statin Therapy: LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B in Type 2 Diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS)

    著者: , , , , , , , , , , , - Clinical Chemistry 2009 被引用: 93